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Summary
Objective: The purpose of this study was to investigate whether the effect of treatment with hyaluronic acid (HA) on cartilage in osteoarthritis
(OA) can be determined by measuring the magnetic resonance (MR) T2 value of cartilage in an anterior cruciate ligament transection (ACLX)
animal model.
Method: Eighteen male Sprague Dawley rats were separated randomly into three groups (n¼ 6 for each group). Group 1 was given ACLX and
intra-articular (IA) normal saline (NS) injection (ACLXþNS), group 2 was given ACLX and IA HA injection (ACLXþHA), and group 3 was the
sham control. The ACLXþNS and ACLXþHA groups received ACLX on the right knee at 8 weeks of age and were then treated with IA NS or
HA injection once a week, respectively, for 4 weeks starting at 13 weeks of age. In the sham-control group, the right knee joint was opened
surgically but ACLX was not performed at 8 weeks of age. MR T2 measurements were obtained on all rats at 8, 12, and 21 weeks of age, and
histological Mankin scoring was performed at 21 weeks of age.
Results: Five weeks after the 4-week treatment, the MR T2 value of the ACLX right knee cartilage was signiﬁcantly lower in ACLXþHA
(29.58 1.12 ms) than in ACLXþNS (32.04 1.39 ms) (P< 0.05). Five weeks after the 4-week treatment, the Mankin score of the ACLX
right knee was signiﬁcantly lower in ACLXþHA (3.3 0.81) than in ACLXþNS (7.3 1.03) (P< 0.001). The T2 value was signiﬁcantly
and positively correlated with the Mankin score in the ACLXþNS (r¼ 0.77, P< 0.05) and ACLXþHA (r¼ 0.69, P< 0.05) groups.
Conclusion: This study demonstrates the feasibility of quantitative MR T2 measurement in the early assessment of HA treatment efﬁciency in
a cartilage degeneration model.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is a common chronic disease character-
ized by progressive degradation of cartilage, synovial
inﬂammation, and impairment of the supporting tissues of
the joint1. Patients with OA frequently experience chronic
pain symptoms, and OA has become a major public health
problem because of the rapidly increasing population of
older people2. Because of the biomechanical properties of
hyaluronic acid (HA), intra-articular (IA) injection of HA is
used widely as a viscosupplement in the treatment of OA-
related pain symptoms3e9. In addition to the symptomatic*Address correspondence and reprint requests to: Guo-Shu
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54efﬁcacy of exogenously administered HA, several preclini-
cal and clinical studies have demonstrated that HA treat-
ment has considerable biological activity in OA, including
regulation of joint repair through its effects on chondrocyte
growth and metabolism; regulation of endogenous HA,
proteoglycan, and collagen synthesis; inhibition of the
expression and function of cartilage-degrading enzymes;
regulation of programmed cell death; and inhibition of the
destructive inﬂammatory response1. However, the effect
of HA treatment on OA disease progression remains contro-
versial and warrants further elucidation.
To further determine the effect of HA on cartilage in clinical
OA treatment, a large number of subjects should be exam-
ined. It is important to develop clinically friendly methods
whose results correlate with the histopathological ﬁndings.
The current imagingmethods to assessOA disease progres-
sion include plain X-rays and conventional magnetic reso-
nance imaging (MRI) scans. Plain X-rays are used to
measure joint space narrowing (JSN), which indirectly
55Osteoarthritis and Cartilage Vol. 18, No. 1reﬂects the thinning or loss of articular cartilage, whereas
conventional MRI scans are usually employed to evaluate
the cartilage morphology and integrity1. Although both tech-
niques (plain X-rays and conventional MRI) can reﬂect the
structural changes in cartilage, neither can detect early
changes in cartilage components in routine clinical settings.
A previous study assessed JSN radiographically in subjects
receiving IA injection of HA or saline in the knees for 1 year
and found no difference between the two groups10. An MRI
study used cartilage defect scoring to assess the structure
of the patellofemoral cartilage in patients receiving HA or sa-
line injection and also found no difference between groups af-
ter 8 weeks of treatment11. It has been suggested that
a longer time, possibly more than 1 year12e16, is needed to
show the structural changes in cartilage after HA treatment.
This time frame exposes a limitation in the ability of state-
of-the-art imaging techniques to detect clinically relevant
changes. A noninvasive, quantitative imaging method for
the early detection of cartilage changes in response to treat-
ment with IA HA injection needs to be developed.
Because of the wide variety of sequence and advanced
technical improvements, MRI allows a more comprehensive
analysis of articular cartilage, including measurement of
relaxation times (T1, T1r, and T2) and diffusion-weighted
parameters, and the use of delayed gadolinium-enhanced
MRI of cartilage (dGEMRIC) to assess the degeneration
of cartilage17e22. Speciﬁcally, the T2 value has been impli-
cated as an imaging biomarker for OA23,24. Several MRI
studies have demonstrated that quantitative T2 measure-
ments can successfully reﬂect subtle changes in water con-
tent and the collagen ﬁber network in articular cartilage,
which are important indicators of cartilage degenera-
tion25e29. The aims of the present study were to determine
whether the MR T2 value measured in the articular cartilage
can provide early evidence of the treatment effect of HA on
OA and whether the T2 value correlates with histological
ﬁndings. To address these questions, anterior cruciate liga-
ment transection (ACLX) was performed on rats to induce
cartilage degeneration in an animal model. Noninvasive
MR T2 measurements and histological analysis were
performed to quantify the effects of HA.Materials and methodsANIMALSThe experiments were approved by the local institutional review board
and were performed in accordance with the National Institutes of Health
guidelines for the treatment of experimental animals. Eighteen male SpragueACLX+NS 
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Fig. 1. The protocol designs for the ACLXþNS, ACLXþHA, and sham-
(, ) observation, ( ) MRI T2 experimDawley rats aged 8 weeks and weighing around 300 g were randomly sep-
arated into three groups (n¼ 6 for each group). Group 1 was given ACLX
and IA injection of normal saline (ACLXþNS), group 2 was given ACLX
and IA injection of HA (ACLXþHA), and group 3 was the sham-control
group. HA sodium salt from rooster comb (Sigma-Aldrich, Saint Louis, MO,
USA) was prepared at a concentration of 2.5 mg/mL in NS.
The protocol design for the ACLXþNS, ACLXþHA, and sham-control
groups is illustrated in Fig. 1. In the ACLXþNS and ACLXþHA groups,
the right anterior cruciate ligament was transected at 8 weeks of age to
induce cartilage degeneration. These groups were given IA injection of NS
(ACLXþNS) or HA (ACLXþHA) once a week for 4 weeks starting at 13
weeks of age. These two conditions were intended to show the treatment
effect of HA in the experimental cartilage degeneration induced by ACLX.
In the sham-control group, the right knee joint of the experimental rats was
opened surgically at 8 weeks of age, but the ACLX was not performed
and the rats received no treatment. The left knee remained untouched in
all groups.
At week 0 following the grouping (i.e., 8 weeks of age), all rats in the three
groups were assigned to the MR T2 experiments. After ACLX surgery in
ACLXþNS and ACLXþHA, the rats were housed separately, two rats per
cage, in sanitary ventilated rooms, and cartilage degeneration was allowed
to develop. At 4 weeks after ACLX surgery (i.e., at 12 weeks of age),
ACLXþNS and ACLXþHA were assigned to the MR T2 experiments. The
experimental knees of ACLXþNS and ACLXþHAwere given an IA injection
of NS (200 mL) or HA (200 mL, 0.5 mg; molecular weight, 1000 kDa), respec-
tively, once eachweek for 4weeks (i.e., onweeks 5, 6, 7, and 8 after ACLX sur-
gery). At 13 weeks after ACLX surgery (21 weeks of age), ACLXþNS and
ACLXþHA were assigned to the MR T2 experiments and were then killed
to provide samples for histological Mankin score grading30e32.
In the sham-control group, after the sham operation on the right knee joint,
the rats were also housed separately, two rats per cage, in sanitary venti-
lated rooms. At 4 and 13 weeks after the sham operation, the rats were as-
signed to the MR T2 experiments. At 13 weeks after the sham operation, the
rats were killed to provide samples for histological Mankin score grading.MR T2 MEASUREMENTAll rats used in the MRI experiments were anesthetized and positioned
supinely with the forelegs ﬁxed to the side and the rear legs stretched straight
in a custom-made, MR-compatible device. A birdcage coil with an inner
diameter of 72 mm was used as the transmitter coil, and a separate quadra-
ture surface coil (Bruker, Ettlingen, Germany) for signal detection was placed
above both knee joints to achieve maximum signal intensity. The intrinsic sig-
nal-to-noise ratio (SNR) is inversely proportional to the dimension of the coil.
Because it has a smaller dimension than a volume coil, the surface coil yields
a better SNR for a local imaging ﬁeld. Although the surface coil exhibits an
inhomogeneous receiving proﬁle, the measurements of T2 relaxation time
were not inﬂuenced for two reasons. First, the entire articular cartilage was
within a relatively restricted region. Second, T2 is a decaying time constant
whose estimation does not rely on the absolute signal intensity; thus, the
inhomogeneous receiving ﬁeld led to noticeable T2 estimation imprecision
only at the edge of the imaging ﬁeld of view. The entire device was placed
in an Oxford Instruments (Bruker, Ettlingen, Germany) 200/300 magnet
(4.7 T, 33 cm clear bore) equipped with an actively shielded Oxford gradient
coil (16 cm inner diameter, 18 G/cm, 200 ms rise time).
After three-plane tripilot imaging, 20 contiguous axial T2-weighted images
were acquired for the purpose of later slice positioning using a turbo spin echo
sequence with repetition time (TR)¼ 3500 ms, echo time (TE)¼ 40 ms, echo
train length¼ 8, slice thickness¼ 500 mm, matrix size¼ 256 128, in-plane
resolution¼ 156 312 mm2, number of excitations (NEX)¼ 4, and acquisitioninjection 
 (once a week) 
13 weeks 8 weeks
T2
injection 
control groups. Time scale: ( ) OA development, ( ) treatment,
ent, ( ) Mankin score analysis.
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the rats at different times, we followed the procedures used in our previous
study30. In this experiment, two sets of three contiguous slices covered
most of the femorotibial cartilage plus one sagittal plane placed in the middle
of each knee joint, making a total of 14 slices acquired for both knee joints of
each rat. The imaging planes placed to measure T2 are shown in Fig. 2. Fol-
lowing the slice positioning, T2 measurements were made using a multislice
multiecho spin echo sequence with TR¼ 4500 ms; TE¼ 10, 20, 30, 40, 50,
60, 70, and 80 ms; slice thickness¼ 500 mm; matrix size¼ 256 256;
in-plane resolution¼ 117 100 mm2; NEX¼ 4; and acquisition time¼ 1 h
16 min 48 s. The total scan time including the rat preparation was about 2 h.IMAGE PROCESSINGAfter image acquisition was complete, the cartilage relaxation time was
estimated on a pixel-by-pixel basis using the least-square, single-exponential
curve-ﬁtting method on a MATLAB 7.0 (MathWorks, Natick, MA, USA) soft-
ware platform. Two parameters, M0 (spin density) and T2 (transverse relax-
ation time), were determined by ﬁtting the signal magnitude from echoes of
the multislice multiecho experiment to the spinespin relaxation signal decay.
After completing the T2 estimation, regions of interest (ROIs) were placed
manually on the contact region of the femorotibial cartilage by referencing to
the ﬁrst-echo image to calculate the mean and standard deviation (SD) of the
T2 relaxation time30. The ROI was deﬁned as described in our previous re-
port30. The average numbers of pixels for the ROIs were around 50 and 45
per slice in the experimental rats with healthy and degenerative cartilage,
respectively. The SNRs in the femorotibial cartilage from the ﬁrst to the
eighth echo were about 16.4, 11.5, 6.5, 5.4, 3.3, 3.1, 2.4, and 2.2. In this
study, some of the image data (n¼ 1 for both knees of ACLXþNS at
week 4, n¼ 2 for both knees of ACLXþNS at week 13, and n¼ 1 for both
knees at week 0 in the sham group) were corrupted because of involuntary
motion that caused repeated ghosting signals along the phase-encoding
direction, and these were discarded from the statistical analysis. To minimize
manual discrepancies in the positioning of the ROIs, the shapes of the ROIs
were drawn by two operators well trained in knee cartilage MR imaging
(MCC, PHT), and both ROIs were reconﬁrmed by an experienced musculo-
skeletal radiologist (GSH). The results shown in this paper are the average of
two measurements.HISTOLOGICAL ANALYSISTo identify the histological processes, the rats from each group were sac-
riﬁced 13 weeks after the ACLX surgery or sham operation. Both knee joints
were removed, ﬁxed in neutral formalin, and decalciﬁed in a rapid decalciﬁer
(Nihon Shiyaku Industries Ltd., Osaka, Japan) for further sectioning31. After
decalciﬁcation, the knee joint tissue was cut in half along the midsagittal line.
Each half was cut from the lateral and medial femoral condyles, and from the
lateral and medial tibial plateau to create four pieces of cartilage sections for
each joint. Specimens from the parafﬁn-embedded blocks were cut into 5 mm
sections twice to obtain eight sections for hematoxylin and eosin (H&E), and
eight sections for Safranin O staining. Microscopic examination was used to
grade the cartilage health according to Mankin’s histological grading, which
produces scores to assess structure (0e6 points), cellularity (0e3 points),
tidemark integrity (0e1 point), and matrix staining (0e4 points)32. ScoringFig. 2. Prescription for the 14 slices for the T2 experiments in the axial (a) a
of the medial and lateral femorotibial condyles, and two single swas based on the most severe histological changes seen in each cartilage
section.STATISTICAL ANALYSISStudent’s t test was used to compare the T2 values between groups. The
ManneWhitney U test was used to compare the Mankin scores between
groups. One-way analysis of variance (ANOVA) for multiple comparisons
was used to examine the difference in the time evolution of T2 values
between the untouched left knees and the ACLX right knees in all groups.
The ManneWhitney U test was used to compare the rate of T2 change
between groups. P< 0.05 was considered signiﬁcant. Spearman correlation
coefﬁcients were also calculated between the MR T2 values and Mankin
scores in the rat knees. The interobserver variability was assessed by calcu-
lating the Pearson correlation coefﬁcient. The root-mean-square average
coefﬁcient of variation (CVRMS) was used to assess the reproducibility in
six repeated T2 measurements of the 8-week-old normal rat knee cartilage,
and CV values <10% were interpreted as good33.ResultsMR T2 ANALYSISIn ACLXþNS, the T2 values at week 0 (before ACLX
surgery) were 27.06 1.44 ms in the right and
26.94 1.11 ms in the left knee cartilage, and these values
did not differ signiﬁcantly. At week 4 after ACLX surgery, the
T2 values were 28.31 1.22 ms in the ACLX right knee and
26.39 0.79 ms in the untouched left knee cartilage
(P< 0.05). At week 13 after ACLX surgery, the T2 value in-
creased to 32.04 1.39 ms in the right ACLX knee cartilage
but remained near the baseline level (26.81 0.85 ms) in
the untouched left knee cartilage (P< 0.01 between right
and left knees). One-way ANOVA also showed a signiﬁcant
difference in T2 values over time between the left and right
knee cartilage (P< 0.001). The trend of T2 values in
ACLXþNS was consistent with that observed in a group
that underwent ACLX only in our previous study30.
Figure 3(a) shows the means and SDs of the T2 values in
the cartilage of both knees in ACLXþNS during the course
of cartilage degeneration.
In ACLXþHA, the T2 values at week 0 were
26.99 1.08 ms in the right and 26.65 0.67 ms in the
left knee cartilage, and these values did not differ signiﬁ-
cantly. At week 4 after ACLX surgery, the T2 values were
29.81 1.19 ms in the ACLX right knee and
27.17 0.38 ms in the untouched left knee cartilagend coronal (b) planes. The three slices were placed parallel to each
lices were located on the middle lines of the knee joints.
Fig. 3. Plots of cartilage T2 (meanSD) measured at weeks 0, 4,
and 13 in the ACLXþNS (a) ACLXþHA (b) and sham-control (c)
groups. Cartilage T2 was measured separately in the operated right
knee and the untouched left knee of all rats. Asterisks indicate sig-
niﬁcant differences (P< 0.05).
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the 4-week HA treatment), the T2 values were
29.58 1.12 ms in the right knee and 26.43 0.96 ms in
the left knee cartilage (P< 0.05). The T2 values in the
ACLX right knee cartilage did not differ signiﬁcantly at
week 4 and week 13. Figure 3(b) shows the means and
SDs of the cartilage T2 values in ACLXþHA.
At week 0 and week 4 after the ACLX surgery, the T2
values did not differ signiﬁcantly for either knee between
ACLXþNS and ACLXþHA. In contrast, at week 13 after
the ACLX surgery (after 4 weeks of HA or NS treatment),
the T2 value was signiﬁcantly lower in ACLXþHA than in
ACLXþNS (P< 0.05). To conﬁrm that the lower T2 value
in ACLXþHA did not reﬂect residual HA in the knee carti-
lage, we compared the T2 values in the knee cartilage
from the untouched knees treated with and without HA
injection, and found no signiﬁcant differences.Using the T2 values at week 4 as the reference values,
the rates of change in the T2 values were calculated for
the treated right knees from week 4 to week 13. The rates
of change in the T2 values for the treated right knees in
ACLXþNS and ACLXþHA from week 4 to week 13 after
ACLX (5 weeks after the 4-week NS or HA treatment)
increased by 13.1% and 3.3%, respectively. The rate of
change differed signiﬁcantly between ACLXþNS and
ACLXþHA (P< 0.0001).
In the sham-control group, the T2 values remained nearly
constant and did not differ signiﬁcantly between the surgi-
cally wounded right and untouched left knee cartilage at
any time (P¼ 0.637). The means and SDs of the T2 values
for the sham-control group are shown in Fig. 3(c).
The interobserver correlation coefﬁcients for the ROI
measurements were high (r¼ 0.92, P< 0.01) in all rats.
The CVRMS of six repeated T2 measurements on the normal
rat knee cartilage was 7.18%, indicating good reproducibility.HISTOLOGICAL ANALYSISIn ACLXþNS, at week 13 after the ACLX surgery, the
Mankin scores were 7.3 1.03 points in the ACLX right
knee and 1.0 0.89 points in the untouched left knee carti-
lage (P< 0.0001). In ACLXþHA, the Mankin scores were
3.3 0.81 points in the ACLX right knee and 0.5 0.55
points in the untouched left knee cartilage (P< 0.0001).
Comparison of the Mankin scores in the right ACLX knee
showed signiﬁcantly lower scores in ACLXþHA than in
ACLXþNS (P< 0.001) but no signiﬁcant difference in
scores between the untouched left knees in the two groups.
The results show that IA HA injection was effective in stabi-
lizing or retarding experimental cartilage degeneration
induced by ACLX.
In the sham-control group, the Mankin scores did not dif-
fer signiﬁcantly between knees. The scores were
0.83 0.75 points in the skin-wounded right knee and
0.5 0.54 in the untouched left knee cartilage. This result
shows that surgical wound of the skin of the knee caused
no signiﬁcant cartilage changes in the microscopic tissue
characteristics. Table I shows the Mankin scores for the
cartilage in both knees for the ACLXþNS, ACLXþHA,
and sham-control groups. Figure 4 shows representative
sections of articular cartilage.CORRELATIONAL ANALYSISThe MR T2 values and Mankin scores measured at 13
weeks after ACLX were correlated in the cartilage in both
knees for the ACLXþNS, ACLXþHA, and sham-control
groups. Because several MR T2 datasets were corrupted
by motion artifacts, as described above, the corresponding
Mankin scores were omitted from the correlational analysis.
The Spearman correlation coefﬁcients between the MR T2
values and Mankin scores within the ACLXþNS,
ACLXþHA, and sham-control groups were r¼ 0.77
(P< 0.05), r¼ 0.69, (P< 0.05), and r¼ 0.52 (P¼ 0.08), re-
spectively (Fig. 5), indicating signiﬁcant positive correlations
between the MR T2 values and Mankin scores in the
ACLXþNS and ACLXþHA groups.Discussion
We used an experimental ACLX-induced cartilage
degeneration animal model to demonstrate the feasibility
of MR T2 measurement in the early evaluation of the
Table I
Mankin scores (points) of the left and right knees for all rats measured at week 13 in the ACLXþNS, ACLXþHA, and sham-control groups
ACLXþNS ACLXþHA Sham-control
Left knee Right knee Left knee Right knee Left knee Right knee
1 9 1 3 1 1
0 6 0 4 0 0
0 7 0 2 0 0
2 7 1 4 1 1
1 7 1 4 1 1
2 8 0 3 0 2
1.0 0.9* 7.33 1.03*,y 0.5 0.55* 3.33 0.82*,y,z 0.5 0.55* 0.83 0.75*
*Data are expressed as meanSD.
yP< 0.005 compared with the left knee of the same group.
zP< 0.05 compared with the right knee of the ACLXþNS group.
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value and the Mankin score of the ACLX knee cartilage
were signiﬁcantly lower in ACLXþHA than in ACLXþNS,
and that the T2 value correlated well with the Mankin score.
Our ﬁndings are important because, to our knowledge, the
current methods for routine clinical imaging assessment
do not detect early changes in the cartilage content1,2 and
cannot be used to evaluate the efﬁcacy of HA in the initial
stages of OA treatment.
A previous study showed that the proteoglycan content in
the articular cartilage decreases markedly with aging and
disease34. The depletion of proteoglycan leads to an in-
crease in the space inside the porous matrix of the articular
cartilage, which in turn is ﬁlled by an inﬂux of water25. As the
mobility and the amount of water increase, the regional T2
value in the cartilage increases35,36. The decrease in pro-
teoglycan content occurs in the earliest stages of degrada-
tion, before any morphological changes in the articular
cartilage25. dGEMRIC has been shown to detect early
changes of proteoglycan content; however, injection of
a contrast agent is needed and the image acquisition time
is longer22. Hence, MR T2 measurement is a potential
method for identifying disease progression in the early
stages of OA23e30. The new information provided by the
present study is that MR T2 measurement can be used to
evaluate the early effect of HA. Using T2 measurement in
the ACLX-induced OA animal model, we found a signiﬁcant
increase in T2 in the ACLXþNS group, whereas T2 in-
creased less in the ACLXþHA group after the 4-week
treatment. From these results, we expect that MR T2
measurement will be far more sensitive than conventionalFig. 4. Histological features of articular cartilage. (a) The articular cartilage
cartilage surface and regular arrangement of the chondrocytes. (b) Experi
tion, and matrix degeneration in the ACLXþNS rats was identiﬁed clearly
mildly rough surface and focal matrix degeneration. The degeneration sev
rats. (H&E,radiographic JSN and MRI morphological analysis in the
monitoring of HA treatment effects.
The change in the T2 value in articular cartilage is asso-
ciated with various factors, including increased water con-
tent14,37, decreased glycosaminoglycan concentration,
proteoglycan size29,34,38, and changes in collagen ﬁber ori-
entation22,37. Our ﬁndings show that, despite a range of
possible causal mechanisms, cartilage degeneration is gen-
erally reﬂected in the T2 value. We found that HA treatment
prevented the increase in the T2 value in experimental
ACLX-induced OA, reinforcing the concept that HA treat-
ment slows cartilage degeneration in OA. The changes in
MR T2 measurement were supported by the postoperative
histology. In our recent report, Chou et al.30 showed a high
positive correlation between water content and the T2 value
in articular cartilage, which validates the use of the MR T2
measurement to investigate the changes in cartilage con-
tent following HA or other pharmacological treatment in
the same subject without the need for invasive procedures.
In the present study, the positive correlation between the T2
values and Mankin scores within each treatment group indi-
cates that the T2 value is useful for predicting the clinical
outcome in cartilage treated with HA. In this study, the dif-
ferences in the Mankin scores between the treatment
groups were more signiﬁcant (P< 0.001) than the differ-
ences in T2 mapping between groups (P< 0.05). A possi-
ble explanation is that the Mankin score is a broader
measure of structural integrity, tidemark integrity, cellularity,
and proteoglycan content and distribution, and that the T2
value measures subtle changes in water content caused
by changes in proteoglycans and collagen within thefrom the sham-control rats showed normal histology with a smooth
mentally induced cartilage degeneration with ﬁbrillation, cleft forma-
. (c) The articular cartilage from the ACLXþHA rats demonstrated
erity in the ACLXþHA rats is less than that seen in the ACLXþNS
400)
Fig. 5. The distribution and correlation of T2 values (ms) and Man-
kin scores (points) of the ACLX þNS (diamonds), ACLX þHA
(squares), and sham-control (triangles) rats in this study. Each
symbol represents one data point obtained from one knee joint.
Solid and hollow symbols indicate the operated right and the
untouched left knee cartilage, respectively. Signiﬁcant positive
correlations between the T2 values and Mankin scores were found
in the ACLXþNS and ACLXþHA groups.
59Osteoarthritis and Cartilage Vol. 18, No. 1cartilage. In contrast, we found a highly signiﬁcant differ-
ence in the rate of change in the T2 value for the treated
right knee from week 4 after ACLX to week 13 between
ACLXþNS and ACLXþHA (P< 0.0001). This ﬁnding
suggests that MR T2 measurement is a feasible method
to assess the effects of HA treatment on cartilage
degeneration.
Although our present study demonstrated that the re-
sponse to HA treatment could be monitored by the T2 value
in the early stages, several issues warrant further elucida-
tion. First, although various types of HA have been used
to treat OA in animals, the current clinical data show that
only Hyalgan has potential to modify disease1. Veriﬁcation
in the clinical context is necessary before applying MR T2
measurement as the method to monitor the major out-
comes. Second, during the measurement of the T2 value,
the selection of the ROI is important. Inaccurate positioning
of the ROI and inclusion of the synovial ﬂuid or joint effusion
causes over- or underestimation of the T2 value30. Caution
should be exercised when interpreting the data when the
ROIs are not selected appropriately.
There are several weaknesses in our study. First, we
placed the ROIs manually for T2 estimation. Erroneous in-
clusion of the synovial ﬂuid or joint effusion would cause
T2 overestimation. To avoid this, where synovial ﬂuid was
seen to be present because of femorotibial dislocation,
which occurred in some rats with ACLX, we placed two
ROIs separately on the femoral and tibial hyaline cartilage.
Therefore, we believe that inclusion of synovial ﬂuid and
joint effusion had been minimized. Second, because of
the magic angle effect, the intensity and T2 value may
vary depending on the angle between the main magnetic
ﬁeld and cartilage ﬁber orientation39e41. Therefore, there
is some deviation of T2 values between various portions
of cartilage. In this study, to minimize the magic angle
effect, we investigated only the contact region of the femoral
and tibial cartilage, which is a relatively small, restricted
area that exhibits similar cartilage orientation with respect
to the direction of the main magnetic ﬁeld.
To our knowledge, this is the ﬁrst study to demonstrate
the feasibility of MR T2 measurement in the earlyassessment of HA treatment efﬁciency. We showed that
the T2 value in articular cartilage was signiﬁcantly lower in
ACLXþHA than in ACLXþNS. The measured T2 values
correlated well with the Mankin scores, demonstrating that
MR T2 measurement can provide a noninvasive, early esti-
mate of the treatment efﬁcacy of HA in an animal model of
degenerative cartilage after ACLX. This method may be
useful for grading cartilage degeneration and for evaluating
the effect of IA HA injection in the clinical treatment of OA.Conﬂict of interest
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